Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Currax Pharmaceuticals
Currax Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Onzetra
Sumatriptan
2016-01-27
2024-2036
Migraine disorders
,
Cluster headache
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
Silenor
Doxepin
2010-03-17
2027-2030
Atopic dermatitis
,
Pruritus
,
Pain
,
Anxiety disorders
,
Psychotic affective disorders
,
Depressive disorder
Treximet
Naproxen
,
Sumatriptan
2008-04-15
2025-2026
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Common cold
,
Toothache
,
Dysmenorrhea
,
Gout
,
Gastroesophageal reflux
,
Helicobacter infections
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Nausea
,
Sleep initiation and maintenance disorders
,
Allergic rhinitis perennial
,
Urticaria
,
Motion sickness
,
Sneezing
,
Anxiety disorders
,
Sinusitis
,
Asthma
,
Stomach ulcer
,
Migraine disorders
,
Cluster headache
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Naproxen
healthy volunteers/patients
,
malnutrition
Sumatriptan
healthy volunteers/patients
Doxepin
ataxia
,
healthy volunteers/patients
Benzocaine
bronchopulmonary dysplasia
,
retinopathy of prematurity
,
hereditary angioedemas
,
angioedema
,
gaucher disease
,
ulcerative colitis
,
colitis
,
ulcer
Lorcaserin
healthy volunteers/patients
,
marijuana abuse
,
breast neoplasms
,
digestive system neoplasms
,
peripheral nervous system diseases
,
pharmacokinetics
,
liver diseases
,
hepatic insufficiency
,
renal insufficiency
,
cocaine-related disorders
,
tobacco use disorder
,
alcoholism
,
alcohol drinking
,
tobacco smoking
,
cannabis
,
sepsis
,
paresis
,
muscle weakness
,
asthenia
,
hypertension
,
dyslipidemias
,
sleep apnea syndromes
,
smoking cessation
,
opioid-related disorders
,
epilepsy
,
myoclonic epilepsies
,
substance-related disorders
,
seizures
,
obesity
,
weight loss
,
overweight
,
cardiovascular diseases
,
weight gain
,
body weight
,
schizophrenia
,
psychotic disorders
,
type 2 diabetes mellitus
,
diabetes mellitus
,
drug resistant epilepsy
Histone-arginine methyltransferase carm1
neoplasms
,
cognition disorders
,
sleep wake disorders
,
parasomnias
,
disorders of excessive somnolence
,
sleepiness
,
ulcerative colitis
,
colitis
,
ulcer
,
renal cell carcinoma
,
carcinoma
,
pain
,
acute pain
,
hiv infections
,
rheumatoid arthritis
,
neoplasm metastasis
,
chronic renal insufficiency
,
kidney diseases
,
vitamin d deficiency
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
type 1 diabetes mellitus
,
ketosis
,
hypothyroidism
,
healthy volunteers/patients
Prudoxin
ataxia
,
healthy volunteers/patients
Lorcaserin hydrochloride anhydrous
smoking cessation
Surlorian
glaucoma
,
pharmacokinetics
,
acute pain
,
asthma
,
ocular hypertension
,
open-angle glaucoma
,
multiple myeloma
,
plasma cell neoplasms
,
healthy volunteers/patients
,
erectile dysfunction
,
gastrointestinal neoplasms
,
renal cell carcinoma
,
neoplasms
,
triple negative breast neoplasms
,
prostatic neoplasms
,
carcinoma
,
lung neoplasms
,
squamous cell carcinoma of head and neck
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
lymphoma
,
hypogonadism
,
small cell lung carcinoma
,
squamous cell carcinoma
,
sarcoma
,
castration-resistant prostatic neoplasms
,
chronic hepatitis
,
colorectal neoplasms
,
stomach neoplasms
,
glioblastoma
,
biliary tract neoplasms
,
hypertension
,
uterine cervical neoplasms
,
adenocarcinoma
,
transitional cell carcinoma
,
liver diseases
,
gastrointestinal diseases
,
virus diseases
,
rna virus infections
,
digestive system diseases
,
viral hepatitis human
,
flaviviridae infections
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
syndrome
,
disorders of excessive somnolence
,
sleepiness
,
papillomavirus infections
,
vaginal neoplasms
,
vulvar neoplasms
,
condylomata acuminata
,
migraine disorders
,
endometrial neoplasms
,
esophageal neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
esophageal squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
head and neck neoplasms
,
malignant mesothelioma
,
mesothelioma
,
x-linked bulbo-spinal atrophy
,
prostatic hyperplasia
,
sarcopenia
,
muscular atrophy
,
eunuchism
,
hypertrophy
,
urologic neoplasms
,
hepatocellular carcinoma
,
urinary bladder neoplasms
,
liver neoplasms
,
microsatellite instability
,
hidradenitis suppurativa
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic hepatitis c
,
melanoma
,
vomiting
,
obesity
,
nausea
,
neoplasm metastasis
,
anesthesia
,
fever
,
diarrhea
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
eye diseases
,
overweight
,
polycystic kidney diseases
,
neuralgia
,
postherpetic neuralgia
,
hepatitis
,
hepatitis a
,
hepatitis c
,
hiv infections
,
hiv
,
infections
,
communicable diseases
,
acquired immunodeficiency syndrome
,
herpes zoster
,
mumps
,
measles
,
chickenpox
,
rubella
,
kidney diseases
,
hepatitis a virus
,
hemorrhage
,
chronic renal insufficiency
,
chronic disease
,
drug-related side effects and adverse reactions
Lorcaserin hydrochloride hemihydrate
smoking cessation
Isoxaflutole
therapeutic equivalency
,
healthy volunteers/patients
,
heart failure
,
cardiovascular diseases
,
heart diseases
,
cardiac arrhythmias
,
laparoscopy
,
growth
,
obesity
,
diet therapy
,
acute lung injury
,
lung injury
,
type 2 diabetes mellitus
,
body weight changes
,
atrial fibrillation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use